XML 17 R4.htm IDEA: XBRL DOCUMENT v3.4.0.3
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
¥ in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2015
USD ($)
$ / shares
shares
Dec. 31, 2015
CNY (¥)
¥ / shares
shares
Dec. 31, 2014
CNY (¥)
¥ / shares
shares
Dec. 31, 2013
CNY (¥)
¥ / shares
shares
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) [Abstract]        
Revenues, net of business tax, value-added tax and related surcharges (including financing lease income from related party amounting to RMB2,083, RMB1,194 and RMB252(US$40) for the years ended December 31, 2013, 2014 and 2015, respectively) $ 95,169 ¥ 616,485 ¥ 606,883 ¥ 563,124
Cost of revenues (54,546) (353,336) (274,562) (217,655)
Gross profit 40,623 263,149 332,321 345,469
Operating expenses:        
Selling expenses (17,416) (112,815) (95,096) (104,667)
General and administrative expenses (including consultation service fees to related party amounting to nil , nil and RMB113(US$17) for the years ended December 31, 2013, 2014 and 2015, respectively) (20,524) (132,952) ¥ (53,576) ¥ (84,506)
Impairment of long-lived assets (3,570) (23,125)
Operating income (loss) (887) (5,743) ¥ 183,649 ¥ 156,296
Interest expense (including interest expense to related party amounting to nil, nil and RMB6,705(US$1,035) for the years ended December 31, 2013, 2014 and 2015, respectively) (8,215) (53,214) (53,470) (36,884)
Foreign exchange gain 1,597 10,348 9,585 784
Loss from disposal of property, plant and equipment (651) (4,220) (3,955) (1,235)
Interest income 3,465 22,447 21,208 ¥ 9,828
Changes in fair value of derivative 5,207 33,731 ¥ 2,605
Loss on debt extinguishment (5,657) (36,648)
Income (loss) from equity method investments (860) (5,572) ¥ 13,911 ¥ 13,470
Other income, net 5,190 33,617 2,113 2,010
Income (loss) from continuing operations before income tax (811) (5,254) 175,646 144,269
Income tax expenses (11,427) (74,025) (80,850) (63,838)
Net income (loss) from continuing operations $ (12,238) ¥ (79,279) 94,796 80,431
Net income from discontinued operations 25,476 10,765
Net income (loss) $ (12,238) ¥ (79,279) 120,272 91,196
Net income (loss) attributable to noncontrolling interests (151) (975) (4,437) 5,303
Net income (loss) attributable to ordinary shareholders $ (12,087) ¥ (78,304) ¥ 124,709 ¥ 85,893
Earnings (loss) per share        
From continuing operations | (per share) $ (0.09) ¥ (0.58) ¥ 0.70 ¥ 0.61
From discontinued operations | (per share) 0.22 0.03
Basic | (per share) $ (0.09) ¥ (0.58) 0.92 0.64
From continuing operations | (per share) $ (0.09) ¥ (0.58) 0.70 0.61
From discontinued operations | (per share) 0.22 0.03
Diluted | (per share) $ (0.09) ¥ (0.58) ¥ 0.92 ¥ 0.64
Weighted average number of shares outstanding:        
Basic 134,546,772 134,546,772 134,836,300 135,077,172
Diluted 134,546,772 134,546,772 135,180,642 135,077,172
Other comprehensive income (loss), net of tax        
Foreign currency translation $ (4,311) ¥ (27,923) ¥ (3,368) ¥ 1,672
Total other comprehensive income (loss), net of tax (4,311) (27,923) (3,368) 1,672
Comprehensive income (loss) (16,549) (107,202) 116,904 92,868
Comprehensive income (loss) attributable to noncontrolling interests (151) (975) (4,437) 5,303
Comprehensive income (loss) attributable to Concord Medical Services Holdings Limited's shareholders $ (16,398) ¥ (106,227) ¥ 121,341 ¥ 87,565